Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29


Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure.

Robson JC, Dawson J, Cronholm PF, Milman N, Kellom KS, Ashdown S, Easley E, Farrar JT, Gebhart D, Lanier G, McAlear CA, Peck J, Luqmani RA, Shea JA, Tomasson G, Merkel PA.

Patient Relat Outcome Meas. 2018 Jan 4;9:17-34. doi: 10.2147/PROM.S144992. eCollection 2018.


Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Robson JC, Dawson J, Cronholm PF, Ashdown S, Easley E, Kellom KS, Gebhart D, Lanier G, Milman N, Peck J, Luqmani RA, Shea JA, Tomasson G, Merkel PA.

Rheumatol Int. 2018 Apr;38(4):675-682. doi: 10.1007/s00296-017-3855-6. Epub 2017 Nov 9.


New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability.

Kirk JA, Gebhart D, Buckley AM, Lok S, Scholl D, Douce GR, Govoni GR, Fagan RP.

Sci Transl Med. 2017 Sep 6;9(406). pii: eaah6813. doi: 10.1126/scitranslmed.aah6813.


OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Robson JC, Tomasson G, Milman N, Ashdown S, Boonen A, Casey GC, Cronholm PF, Cuthbertson D, Dawson J, Direskeneli H, Easley E, Kermani TA, Farrar JT, Gebhart D, Lanier G, Luqmani RA, Mahr A, McAlear CA, Peck J, Shea B, Shea JA, Sreih AG, Tugwell PS, Merkel PA.

J Rheumatol. 2017 Oct;44(10):1529-1535. doi: 10.3899/jrheum.161139. Epub 2017 Sep 1.


Bacteriophage SP6 encodes a second tailspike protein that recognizes Salmonella enterica serogroups C2 and C3.

Gebhart D, Williams SR, Scholl D.

Virology. 2017 Jul;507:263-266. doi: 10.1016/j.virol.2017.02.025. Epub 2017 Mar 10.


F-Type Bacteriocins of Listeria monocytogenes: a New Class of Phage Tail-Like Structures Reveals Broad Parallel Coevolution between Tailed Bacteriophages and High-Molecular-Weight Bacteriocins.

Lee G, Chakraborty U, Gebhart D, Govoni GR, Zhou ZH, Scholl D.

J Bacteriol. 2016 Sep 22;198(20):2784-93. doi: 10.1128/JB.00489-16. Print 2016 Oct 15.


Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process.

Robson JC, Milman N, Tomasson G, Dawson J, Cronholm PF, Kellom K, Shea J, Ashdown S, Boers M, Boonen A, Casey GC, Farrar JT, Gebhart D, Krischer J, Lanier G, McAlear CA, Peck J, Sreih AG, Tugwell PS, Luqmani RA, Merkel PA.

J Rheumatol. 2015 Nov;42(11):2204-9. doi: 10.3899/jrheum.141143. Epub 2015 Sep 1. Review.


Genome-Wide Reprogramming of Transcript Architecture by Temperature Specifies the Developmental States of the Human Pathogen Histoplasma.

Gilmore SA, Voorhies M, Gebhart D, Sil A.

PLoS Genet. 2015 Jul 15;11(7):e1005395. doi: 10.1371/journal.pgen.1005395. eCollection 2015 Jul.


A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.

Gebhart D, Lok S, Clare S, Tomas M, Stares M, Scholl D, Donskey CJ, Lawley TD, Govoni GR.

MBio. 2015 Mar 24;6(2). pii: e02368-14. doi: 10.1128/mBio.02368-14.


Current status of outcome measure development in vasculitis.

Merkel PA, Aydin SZ, Boers M, Cornell C, Direskeneli H, Gebhart D, Hatemi G, Luqmani R, Matteson EL, Milman N, Robson J, Seo P, Tomasson G.

J Rheumatol. 2014 Mar;41(3):593-8. doi: 10.3899/jrheum.131248. Epub 2014 Jan 15.


Novel high-molecular-weight, R-type bacteriocins of Clostridium difficile.

Gebhart D, Williams SR, Bishop-Lilly KA, Govoni GR, Willner KM, Butani A, Sozhamannan S, Martin D, Fortier LC, Scholl D.

J Bacteriol. 2012 Nov;194(22):6240-7. doi: 10.1128/JB.01272-12. Epub 2012 Sep 14.


Arbuscular mycorrhizal fungal community differs between a coexisting native shrub and introduced annual grass.

Busby RR, Stromberger ME, Rodriguez G, Gebhart DL, Paschke MW.

Mycorrhiza. 2013 Feb;23(2):129-41. doi: 10.1007/s00572-012-0455-x. Epub 2012 Aug 5.


Genome sequence of E. coli O104:H4 leads to rapid development of a targeted antimicrobial agent against this emerging pathogen.

Scholl D, Gebhart D, Williams SR, Bates A, Mandrell R.

PLoS One. 2012;7(3):e33637. doi: 10.1371/journal.pone.0033637. Epub 2012 Mar 14.


The evolution of vascular tissue engineering and current state of the art.

Peck M, Gebhart D, Dusserre N, McAllister TN, L'Heureux N.

Cells Tissues Organs. 2012;195(1-2):144-58. doi: 10.1159/000331406. Epub 2011 Oct 13. Review.


An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal disease.

Ritchie JM, Greenwich JL, Davis BM, Bronson RT, Gebhart D, Williams SR, Martin D, Scholl D, Waldor MK.

Antimicrob Agents Chemother. 2011 Dec;55(12):5469-74. doi: 10.1128/AAC.05031-11. Epub 2011 Sep 26.


Soil Bacteria and Fungi Respond on Different Spatial Scales to Invasion by the Legume Lespedeza cuneata.

Yannarell AC, Busby RR, Denight ML, Gebhart DL, Taylor SJ.

Front Microbiol. 2011 Jun 3;2:127. doi: 10.3389/fmicb.2011.00127. eCollection 2011.


An engineered R-type pyocin is a highly specific and sensitive bactericidal agent for the food-borne pathogen Escherichia coli O157:H7.

Scholl D, Cooley M, Williams SR, Gebhart D, Martin D, Bates A, Mandrell R.

Antimicrob Agents Chemother. 2009 Jul;53(7):3074-80. doi: 10.1128/AAC.01660-08. Epub 2009 Apr 6.


syn,syn-15,17-Di-2-naphthyl-hexa-cyclo-[]hepta-decane deuterochloro-form monosolvate.

Deblase AF, Thong DC, Nadeau JM, Gebhart D, Provo J, Foxman BM.

Acta Crystallogr Sect E Struct Rep Online. 2009 Sep 12;65(Pt 10):o2427-8. doi: 10.1107/S160053680903565X.


[Reflections no humanitarian engagement].

Courcol W, El Homrani F, Geber M, Gebhart D, Helmstetter C, Kreiss A, Leininger C, Leroux S, Mazouzi J, Noudjou J, Altmayer A, Anfray V, Bozarhoun MA, Chartier C, Christen P, De Surmont R, Djouder J, Felder E, Freire MC, Ghazal H, Gnaedig E, Hauchard F, Heiligenstein L, Keck C, Lievre D, Messas H, Paczek C, Vinson M.

Rev Infirm. 2008 Jun;(141):39-40. French. No abstract available.


Retargeting R-type pyocins to generate novel bactericidal protein complexes.

Williams SR, Gebhart D, Martin DW, Scholl D.

Appl Environ Microbiol. 2008 Jun;74(12):3868-76. doi: 10.1128/AEM.00141-08. Epub 2008 Apr 25.


Grassland plant composition alters vehicular disturbance effects in Kansas, USA.

Dickson TL, Wilsey BJ, Busby RR, Gebhart DL.

Environ Manage. 2008 May;41(5):676-84. doi: 10.1007/s00267-007-9064-4.


An unusual case of an erupting microsupernumerary tooth.

Borris TJ, Gebhart DL.

Gen Dent. 1991 Jul-Aug;39(4):286-7. No abstract available.


A reference file system for general dentistry.

Gillon DG, Gebhart DL.

Gen Dent. 1990 Jul-Aug;38(4):272-7. No abstract available.


Postoperative risks of pediatric tonsilloadenoidectomy.

Carithers JS, Gebhart DE, Williams JA.

Laryngoscope. 1987 Apr;97(4):422-9.


Tympanostomy tubes in the otitis media prone child.

Gebhart DE.

Laryngoscope. 1981 Jun;91(6):849-66.


An attachment for the Dermo-jet suitable for use through a laryngoscope.

Miglets AW, Kelly DR, Gebhart DE.

Trans Am Acad Ophthalmol Otolaryngol. 1974 Jul-Aug;78(4):ORL283-4. No abstract available.


Airway obstruction due to a large laryngeal granular cell myoblastoma.

Miglets AW, Gebhart DE, Gregg LO.

Laryngoscope. 1971 Jun;81(6):971-8. No abstract available.


Supplemental Content

Loading ...
Support Center